Daiwa Securities Group
XLRN

Daiwa Securities Group’s Acceleron Pharma XLRN Stock Holding History

Daiwa Securities Group’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-209
Closed -$36K – 1486
2021
Q3 		$36K Buy
209
+89
+74% +$11.6K ﹤0.01% 1079
2021
Q2 		$15K Hold
120
– – ﹤0.01% 1032
2021
Q1 		$16K Buy
120
+7
+6% +$904 ﹤0.01% 1022
2020
Q4 		$14K Sell
113
-225
-67% -$26.4K ﹤0.01% 999
2020
Q3 		$38K Buy
338
+38
+13% +$3.78K ﹤0.01% 954
2020
Q2 		$27K Hold
300
– – ﹤0.01% 1012
2020
Q1 		$27K Hold
300
– – ﹤0.01% 993
2019
Q4 		$16K Sell
300
-29
-9% -$1.32K ﹤0.01% 1033
2019
Q3 		$13K Hold
329
– – ﹤0.01% 1021
2019
Q2 		$14K Hold
329
– – ﹤0.01% 1039
2019
Q1 		$15K Buy
329
+79
+32% +$3.47K ﹤0.01% 1007
2018
Q4 		$11K Hold
250
– – ﹤0.01% 995
2018
Q3 		$14K Hold
250
– – ﹤0.01% 1015
2018
Q2 		$12K Hold
250
– – ﹤0.01% 1048
2018
Q1 		$10K Buy
+250
New +$10.6K ﹤0.01% 1033

Daiwa Securities Group's XLRN Position: Q4 2021 in Review

Daiwa Securities Group sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 209 shares — an estimated $36K sold.

Daiwa Securities Group first reported a position in XLRN in Q1 2018 and held it in 15 quarters. The position peaked at $38K in Q3 2020. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Daiwa Securities Group reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Daiwa Securities Group sold 209 Acceleron Pharma shares in Q4 2021, an estimated $36K.
  • Daiwa Securities Group first reported a position in Acceleron Pharma in Q1 2018 and held it in 15 quarters.
  • Daiwa Securities Group's Acceleron Pharma position peaked at $38K in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Daiwa Securities Group's 13F filing for Q4 2021, filed 3 Feb 2022.